Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials (Q38160099)

30 August 2017

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials (English)

1 reference

randomized controlled trial

30 August 2017

1 reference

inferred from title

cervix uterine cancer

1 reference

12

Julian Peto

1 reference

30 August 2017

Nereo Segnan

8

0 references

Joakim Dillner

2

object named as

Joakim Dillner

1 reference

ORCID Public Data File 2021

30 August 2017

1 reference

Massimo Confortini

1 reference

ORCID Public Data File 2021

Chris J L M Meijer

13

object named as

Chris J L M Meijer

1 reference

30 August 2017

5

Peter J F Snijders

1 reference

30 August 2017

Guglielmo Ronco

1

1 reference

30 August 2017

K Miriam Elfström

3

1 reference

30 August 2017

Sara Tunesi

4

1 reference

30 August 2017

Marc Arbyn

6

1 reference

30 August 2017

Henry Kitchener

7

1 reference

30 August 2017

Clare Gilham

9

1 reference

30 August 2017

Paolo Giorgi-Rossi

10

1 reference

30 August 2017

Johannes Berkhof

11

1 reference

30 August 2017

International HPV screening working group

14

1 reference

30 August 2017

language of work or name

English

0 references

publication date

3 November 2013

1 reference

30 August 2017

1 reference

30 August 2017

383

1 reference

30 August 2017

524-532

1 reference

30 August 2017

9916

1 reference

HPV screening for cervical cancer in rural India

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

The 2001 Bethesda System: terminology for reporting results of cervical cytology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Estimation of confidence limits for the cumulative probability of survival in life table analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Quantitative methods in the review of epidemiologic literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962218-7

7 January 2021

10.1016/S0140-6736(13)62218-7

Identifiers

DOI

1 reference

release_sptgma72m5cdvj4pq7hoy4x3xi

30 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sptgma72m5cdvj4pq7hoy4x3xi

24 November 2022

mapped directly with Wikidata item

1 reference